BioHealth News Archive
Qiagen Acquires Enzymatics, Inks Partnership with ArcherDX – GenomeWeb
Qiagen announced on Sunday that it has acquired the enzyme solutions unit of Enzymatics, a supplier of enzymes used in next-generation sequencing and other…
Read More
Roche to Buy Majority Stake in Foundation Medicine, Leader in Tumor Testing – NYTimes.com
The Swiss pharmaceutical giant Roche said on Monday that it would acquire a majority stake in the tumor-testing company Foundation Medicine for more than…
Read More
Roche Spends $1.03 Billion For Majority Stake In Foundation Medicine
Roche, the world’s largest maker of cancer drugs, is spending $1.03 billion to buy a 56.3% stake in Cambridge, Mass.-based Foundation Medicine, a company…
Read More
Vivek Wadhwa: How Technology Will Eat Medicine – The Accelerators – WSJ
The most significant announcement that Apple made in 2014 wasn’t a larger-sized iPhone. It was that Apple is entering the health-care industry. With HealthKit,…
Read More
Tech Council of Maryland reveals legislative agenda for new governor, lawmakers – The Washington Post
The Tech Council of Maryland plans to outline its legislative priorities Monday as state lawmakers head to Annapolis next week, but lobbyists will have…
Read More
Baltimore bioscience firm PathSensors gets $500K investment to expand in China – Baltimore Business Journal
Balitmore's PathSensors Inc. has received $500,000 from a Chinese investor to expand the bioscience company's footprint in China. The private investor, Michael Song, is…
Read More
GBC will push for angel investor tax credit in 2015 – Baltimore Business Journal
Greater Baltimore Committee wants legislators to establish a state tax credit for angel investors who support early-stage companies. Legislation to create the tax credit…
Read More
Want to help Ebola research? Rockville company makes pitch for clinical trial volunteers – Washington Business Journal
Rockville-based contract research firm Optimal Research announced it will begin clinical trials this month for the Johnson & Johnson (NYSE: JNJ) Ebola vaccine, considered…
Read More
Tetragenetics to partner with MedImmune on antibody drug discovery research – Pharmaceutical Business Review
US-based biotechnology firm Tetragenetics will enter into collaboration with AstraZeneca's global biologics research and development arm MedImmune, on multi-target ion channel drug discovery program.…
Read More
MedImmune committed to three Neuroscience initiatives – Cambridge News
The need to improve and increase research into dementia and other neurodegenerative diseases is widely recognised. In 2012, Prime Minister David Cameron launched his…
Read More
BioBuzz January 2015
Wednesday January 28, 2015 from 5:00 PM to 7:00 PM EST Join the BioBuzz networking group at our next free event. Along with 100's…
Read More
Johns Hopkins looks for alternative funding for research as NIH grants lag – Baltimore Business Journal
Johns Hopkins University President Ronald J. Daniels is scrambling to track down funding for young researchers who are increasingly being passed up for federal…
Read More
How 23andMe Cashes In on Consumers’ Genes – MIT Technology Review
Facebook generates about $8 a year in revenue from each of its users. But what if you offered a company not just your photos…
Read More
Different Research Papers Score Big with Scientists and the Public – Scientific American
Hundreds of research papers are published every day worldwide. But which articles are most discussed and in which circles? To find out, Altmetric in…
Read More
Hogan appoints Evergreen Advisors chair Mike Gill as DBED chief – Baltimore Business Journal
R. Mike Gill, chairman of Columbia investment banking firm Evergreen Advisors, will become the next secretary of the Maryland Department of Business and Economic…
Read More